The role of tunable activation thresholds in the dynamics of autoimmunity

Journal of Theoretical Biology

Volumn 308, Issue , 2012, Pages 45-55

  Blyuss, K B ^a   Nicholson, L B ^b  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Activation thresholds; Autoimmunity; Mathematical model; Virus

Indexed keywords

IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; NUMERICAL MODEL; PEPTIDE; PROTEIN; THRESHOLD; VIRUS;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DYNAMICS; IMMUNE RESPONSE; INNATE IMMUNITY; MATHEMATICAL MODEL; PRIORITY JOURNAL; RECURRENT INFECTION; RELAPSE; REMISSION; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; COMPUTER SIMULATION; HUMANS; KINETICS; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; NUMERICAL ANALYSIS, COMPUTER-ASSISTED; T-LYMPHOCYTES; TIME FACTORS;

EID: 84862185470     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2012.05.019     Document Type: Article

References (55)

1. Altan-Bonnet, G., Germain, R.N., 2005. Modeling T cell antigen discrimination based on feedback control of digital ERK responses. PLoS Biol. 3, e356.
2. Alexander H.K., Wahl L.M. Self-tolerance and autoimmunity in a regulatory T cell model. Bull. Math. Biol. 2011, 73:33-71.
3. Ambrosini Y.M., Yang G.X., Zhang W., Tsuda M., Shu S., Tsuneyama K., Leung P.S.C., Ansari A.A., Coppel R.L., Gershwin M.E. The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis. Clin. Exp. Immunol. 2011, 166:110-120.
4. Ben Ezra D., Forrester J.V. Fundal white dots-the spectrum of a similar pathological process. Br. J. Ophthalmol. 1995, 79:856-860.
5. Bitmansour A.D., Douek D.C., Maino V.C., Picker L.J. Direct ex vivo analysis of human CD4+ memory T cell activation requirements at the single clonotype level. J. Immunol. 2002, 169:1207-1218.
6. Bluestone J.A., Herold K., Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010, 464:1293-1300.
7. Borghans J.A.M., de Boer R.J. A minimal model for T-cell vaccination. Proc. R. Soc. B 1995, 259:173-178.
8. Borghans J.A.M., de Boer R.J., Sercarz E., Kumar V. T cell vaccination and experimental autoimmune encephalomyelitis: a mathematical model. J. Immunol. 1998, 161:1087-1093.
9. Buljevac D., Flach H.Z., Hop W.C.J., Hijdra D., Laman J.D., Savelkoul H.F.J., van der Meché F.G.A., van Doorn P.A., Hintzen R.Q. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 2002, 125:952-960.
10. Burroughs N.J., Oliveira B.M.P.M., Pinto A.A. Autoimmunity arising from bystander proliferation of T cells in an immune response model. Math. Comput. Model. 2011, 53:1389-1393.
11. Carneiro J., Paixão T., Milutinovic D., et al. Immunological self-tolerance: lessons from mathematical modeling. J. Comput. Appl. Math. 2005, 184:77-100.
12. Chastain E.M.L., Duncana D.S., Rodgers J.M., Miller S.D. The role of antigen presenting cells in multiple sclerosis. Biochim. Biophys. Acta Mol. Basis Dis. 2011, 1812:265-274.
13. Coles A.J., Compston D.A. Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N. Engl. J. Med. 2008, 359:1786-1801.
14. Cotsapas C., Voight B.F., Rossinet E., et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet. 2011, 7:e1002254.
15. Davies T.F., Evered D.C., Rees Smith B., Yeo P.P.B., Clark F., Hall R. Value of thyroid-stimulating-antibody determination in predicting the short-term thyrotoxic relapse in Graves' disease. Lancet 1997, 309:1181-1182.
16. Ercolini A.M., Miller S.D. The role of infections in autoimmune disease. Clin. Exp. Immunol. 2008, 155:1-15.
17. Fujinami R.S. Can virus infections trigger autoimmune disease?. J. Autoimmun. 2001, 16:229-234.
18. Grossman Z., Paul W.E. Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses. Proc. Natl. Acad. Sci. USA 1992, 89:10365-10369.
19. Grossman Z., Singer A. Tuning of activation thresholds explains flexibility in the selection and development of T cells in the thymus. Proc. Natl. Acad. Sci. USA 1996, 93:14747-14752.
20. Grossman Z., Paul W.E. Self-tolerance: context dependent tuning of T cell antigen recognition. Sem. Immunol. 2000, 12:197-203.
21. Hellwig K., Gold R. Progressive multifocal leukoencephalopathy and natalizumab. J. Neurol. 2011, 258:1920-1928.
22. Horwitz M.S., Bradley L.M., Harbertson J., Krahl T., Lee J., Sarvennick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 1998, 4:781-785.
23. Iwami S., Takeuchi Y., Miura Y., Sasaki T., Kajiwara T. Dynamical properties of autoimmune disease models: tolerance, flare-up, dormancy. J. Theor. Biol. 2007, 246:646-659.
24. Iwami S., Takeuchi Y., Iwamoto K., Naruo Y., Yasukawa M. A mathematical design of vector vaccine against autoimmune disease. J. Theor. Biol. 2009, 256:382-392.
25. Kerr E.C., Copland D.A., Dick A.D., Nicholson L.B. The dynamics of leukocyte infiltration in experimental autoimmune uveoretinitis. Prog. Retin. Eye Res. 2008, 27:527-535.
26. Kim P.S., Ahmed R. Features of responding T cells in cancer and chronic infection. Curr. Opin. Immunol. 2010, 22:223-230.
27. Korganow A.-S., Ji H., Mangialaio S., et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999, 10:451-461.
28. León K., Faro J., Lage A., Carneiro J. Inverse correlation between the incidences of autoimmune disease and infection predicted by a model of T cell mediated tolerance. J. Autoimmun. 2004, 22:31-42.
29. León K., Lage A., Carneiro J. Tolerance and immunity in a mathematical model of T-cell mediated suppression. J. Theor. Biol. 2003, 225:107-126.
30. León K., Perez R., Lage A., Carneiro J. Modelling T-cell-mediated suppression dependent on interactions in multicellular conjugates. J. Theor. Biol. 2000, 207:231-254.
31. Liu J. FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. Immunol. Today 1993, 291:290-295.
32. Longhi M.S., Maa Y., Mieli-Vergania G., Vergani D. Aetiopathogenesis of autoimmune hepatitis. J. Autoimmun. 2010, 34:7-14.
33. Münz C., Lünemann J.D., Teague Getts M., Miller S.D. Antiviral immune responses: triggers of or triggered by autoimmunity. Nat. Rev. Immunol. 2009, 9:246-258.
34. Naumov Y.N., Naumova E.N., Hogan K.T., Selin L.K., Gorski J. A fractal clonotype distribution in the CD8+ memory T cell repertoire could optimize potential for immune responses. J. Immunol. 2003, 170:3994-4001.
35. Nicholson D., Nicholson L.B. A simple immune system simulation reveals optimal movement and cell density parameters for successful target clearance. Immunology 2008, 123:519-527.
36. Nicholson L.B., Anderson A.C., Kuchroo V.K. Tuning T cell activation threshold and effector function with cross-reactive peptide ligands. Int. Immunol. 2000, 12:205-213.
37. Noest A.J. Designing lymphocyte functional structure for optimal signal detection: voilá, T cells. J. Theor. Biol. 2000, 207:195-216.
38. Nowak M., May R.M. Virus Dynamics 2000, Oxford University Press.
39. Nylander A., Hafler D.A. Multiple sclerosis. J. Clin. Invest. 2012, 122:1180-1188.
40. Olson J.K., Croxford J.L., Calenoff M.A., Dal Canto M.C., Miller S.D. A virus-induced molecular mimicry model of multiple sclerosis. J. Clin. Invest. 2001, 108:311-318.
41. Perelson A.S., Nelson P.W. Mathematical analysis of HIV-1 dynamics in vivo. SIAM Rev. 1998, 41:3-44.
42. Prat E., Martin R. The immunopathogenesis of multiple sclerosis. J. Rehabil. Res. Dev. 2002, 39:187-199.
43. Römer P.S., Berr S., Avota E., et al. Preculture of PBMC at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412. Blood 2011, 118:6772-6782.
44. Santamaria P. The long and winding road to understanding and conquering type 1 diabetes. Immunity 2010, 32:437-445.
45. Scherer A., Noest A., de Boer R.J. Activation-threshold tuning in an affinity model for the T-cell repertoire. Proc. R. Soc. B 2004, 271:609-616.
46. Segel L.A., Jäger E., Elias D., Cohen I.R. A quantitative model of autoimmune disease and T-cell vaccination: does more mean less?. Immunol. Today 1995, 16:80-84.
47. Selin L.K., Varga S.M., Wong I.C., Welsh R.M. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J. Exp. Med. 1998, 188:1705-1715.
48. Stefanova I., Dorfman J.R., Germain R.N. Self-recognition promotes the foreign antigen sensitivity of naive T lymphocytes. Nature 2002, 420:429-434.
49. van den Berg H., Rand D.A. Dynamics of T cell activation threshold tuning. J. Theor. Biol. 2004, 228:397-416.
50. Vickers D.M., Zhang Q., Osgood N.D. Immunobiological outcomes of repeated chalmydial infection from two models of within-host population dynamics. PLoS ONE 2009, 4:e6886.
51. von Herrath M.G., Oldstone M.B.A. Virus-induced autoimmune disease. Curr. Opin. Immunol. 1996, 8:878-885.
52. Wodarz D., Jansen V.A.A. A dynamical perspective of CTL cross-priming and regulation: implications for cancer immunology. Immunol. Lett. 2003, 86:213-227.
53. Wodarz D., Lloyd A.L. Immune responses and the emergence of drug-resistant virus strains in vivo. Proc. R. Soc. B 2004, 271:1101-1109.
54. Wolf S.D., Dittel B.N., Hardardottir F., Janeway C.A. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 1996, 184:2271-2278.
55. Wu H.-J., Ivanov I.I., Darceet J., et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32:815-827.